FDA panel: Study did not show benefit with Avastin
Tuesday, July 20, 2010 - 13:42
in Health & Medicine
(AP) -- Federal health advisers said unanimously Tuesday that a follow-up study of the Roche drug Avastin failed to show meaningful benefits for breast cancer patients.